4//SEC Filing
Schenkein David P 4
Accession 0001439222-24-000087
CIK 0001439222other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:29 PM ET
Size
8.8 KB
Accession
0001439222-24-000087
Insider Transaction Report
Form 4
Schenkein David P
DirectorChief Executive Officer10% Owner
Transactions
- Exercise/Conversion
Restricted stock units
2024-06-13−3,388→ 0 total→ Common stock (3,388 underlying) - Exercise/Conversion
Common stock
2024-06-13+3,388→ 126,242 total
Holdings
- 79,082(indirect: See footnote)
Common stock
- 270,772(indirect: See footnote)
Common stock
Footnotes (4)
- [F1]Shares held by David P. Schenkein 2004 Revocable Trust, of which the reporting person is trustee and beneficiary.
- [F2]Shares held by Amy P. Schenkein 2004 Revocable Trust, of which the reporting person's spouse is trustee and beneficiary.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F4]The restricted stock units were granted on June 13, 2023. The shares underlying the stock units vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001578200
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:29 PM ET
- Size
- 8.8 KB